Physics

A.D. Martin, W.J. Stirling, R.G. Roberts, "New information on parton distributions," Physical Review D, 47:867-82, 1993. Alan D. Martin (Centre for Particle Theory, University of Durham, England): "The use of energetic electrons (and other leptons) to probe the structure of the proton has had a long and successful history. These so-called deep-inelastic experiments have shown that the proton is composed of quark and gluon constitue

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A.D. Martin, W.J. Stirling, R.G. Roberts, "New information on parton distributions," Physical Review D, 47:867-82, 1993.

Alan D. Martin (Centre for Particle Theory, University of Durham, England): "The use of energetic electrons (and other leptons) to probe the structure of the proton has had a long and successful history. These so-called deep-inelastic experiments have shown that the proton is composed of quark and gluon constituents--the more energetic the bombarding electron, the better its resolution and the more partons (quarks and gluons) that are `seen.' Parton distributions describe how the proton's energy is shared among its quark and gluon constituents. By measuring these distributions we can learn about how quarks and gluons interact, and test the theory of the strong interaction.

"In any high-energy collision involving the proton, the interaction takes place at the partonic level. That is, in a collision the proton delivers only part of its energy, since the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies